Molecular Therapy: Difference between revisions
Content deleted Content added
added Category:Genetics journals using HotCat |
No edit summary |
||
Line 16: | Line 16: | ||
| openaccess = |
| openaccess = |
||
| license = |
| license = |
||
| impact = 8. |
| impact = 8.986 |
||
| impact-year = |
| impact-year = 2020 |
||
| ISSNlabel = |
| ISSNlabel = |
||
| ISSN = 1525-0016 |
| ISSN = 1525-0016 |
Revision as of 12:13, 9 July 2021
Discipline | Genetic diseases |
---|---|
Language | English |
Edited by | Seppo Ylä-Herttuala |
Publication details | |
History | 2000–present |
Publisher | |
Frequency | Monthly |
8.986 (2020) | |
Standard abbreviations | |
ISO 4 | Mol. Ther. |
Indexing | |
ISSN | 1525-0016 (print) 1525-0024 (web) |
OCLC no. | 41354718 |
Links | |
Molecular Therapy is a scientific journal, published by Cell Press, that aims to develop and explore "molecular and cellular therapeutics to correct genetic and acquired diseases".[1]
The founder of the journal and its Editor-in-Chief in the first five years was Inder Verma.[2]
References
External links